The nurse is discharging a client from the hospital who has a new prescription for furosemide. Which of the following client statements indicates an understanding of the teaching?

A) Loss of protective respiratory mechanisms due to prolonged irritation or damage:
Individuals with COPD often experience a progressive loss of protective respiratory mechanisms over time. Chronic exposure to irritants such as cigarette smoke leads to inflammation, structural changes in the airways, and destruction of lung tissue, impairing the body's ability to clear mucus, trap foreign particles, and maintain normal lung function. This loss of protective mechanisms contributes to the hallmark symptoms of COPD, including airflow limitation, chronic cough, and increased susceptibility to respiratory infections.

B) Localized swelling and inflammation within the lungs:
While inflammation is a hallmark feature of COPD, it typically manifests as widespread inflammation throughout the lungs rather than localized swelling. In COPD, chronic exposure to irritants leads to a systemic inflammatory response that affects the entire respiratory tract, including the bronchi and alveoli. This inflammation contributes to airway obstruction, mucus hypersecretion, and the development of respiratory symptoms.

C) An acute viral infection of the respiratory tract:
While individuals with COPD are at increased risk of respiratory infections, including viral infections such as influenza and respiratory syncytial virus (RSV), COPD itself is a chronic, progressive respiratory condition characterized by persistent airflow limitation. Acute viral infections may exacerbate COPD symptoms and lead to worsening respiratory function, but they are not inherent features of the disease itself.

D) Inflammation and swelling of the sinus membranes over a prolonged period:
Sinus inflammation and swelling, known as sinusitis, are not typically considered primary features of COPD. While individuals with COPD may experience comorbid conditions such as chronic rhinosinusitis, which can contribute to respiratory symptoms and exacerbations, sinus inflammation is not a defining characteristic of the disease.

This is the correct response. ACE inhibitors are known to cause a persistent, dry, and irritating cough in some individuals. This adverse effect occurs due to the accumulation of bradykinin and other substances in the lungs, leading to increased sensitivity of the cough reflex. The cough typically resolves upon discontinuation of the ACE inhibitor.

B) Respiratory depression:
Respiratory depression is not a common side effect of ACE inhibitors. ACE inhibitors do not directly affect respiratory drive or function in the central nervous system. Therefore, this option is incorrect.

C) Spontaneous pneumothorax:
Spontaneous pneumothorax is not a typical adverse effect associated with ACE inhibitor use. ACE inhibitors do not directly cause the development of pneumothorax, which is characterized by the presence of air in the pleural space. Therefore, this option is incorrect.

D) Pneumonia:
While ACE inhibitors can increase the risk of respiratory infections due to their effect on the immune system, pneumonia is not a specific adverse effect associated with ACE inhibitor use. Pneumonia is typically caused by infectious agents such as bacteria, viruses, or fungi, rather than being a direct effect of ACE inhibitors. Therefore, this option is incorrect.”